SYNOGLIM MV 1.3 is a fixed dose combination medication that contains Voglibose (0.30mg/Tablet), Metformin (500.00mg/Tablet), and Glimepiride (1.00mg/Tablet). Voglibose is an alpha-glucosidase inhibitor that helps control blood sugar levels by delaying the digestion and absorption of carbohydrates. Metformin is a biguanide that improves insulin sensitivity and reduces glucose production in the liver. Glimepiride is a sulfonylurea that stimulates insulin secretion from the pancreas. This combination is used to manage type 2 diabetes mellitus when diet and exercise alone are not sufficient. It helps lower blood sugar levels and improve glycemic control.
- Management of type 2 diabetes mellitus
- Diarrhea
- Nausea
- Hypoglycemia
- Abdominal pain
- Skin rash
Take SYNOGLIM MV 1.3 orally with meals, as directed by your doctor. The dosage and frequency of administration will depend on your individual medical condition. Follow your doctor's instructions carefully.
- Pregnancy - SYNOGLIM MV 1.3 is not recommended for use during pregnancy. Consult your doctor for safer alternatives.
- Alcohol - It is advisable to avoid alcohol while taking SYNOGLIM MV 1.3 as it may increase the risk of lactic acidosis.
- Old Age - Caution is advised while using SYNOGLIM MV 1.3 in elderly patients, as they may be more prone to the side effects of this medication. Your doctor may need to adjust the dosage accordingly.
- Breast Feeding - SYNOGLIM MV 1.3 is not recommended for use while breastfeeding. Consult your doctor for safer alternatives.
- Children - SYNOGLIM MV 1.3 is not recommended for use in children. Consult your doctor for safer alternatives.
- Store at room temperature (20-25°C) -
- Protect from moisture and light -
- Drug-Drug - This medication may interact with other antidiabetic drugs, beta-blockers, corticosteroids, diuretics, and certain medications metabolized by the liver or kidneys. Inform your doctor about all the medicines you are taking.
- Drug-Food - There are no known significant drug-food interactions with SYNOGLIM MV 1.3.
- Drug-Disease - SYNOGLIM MV 1.3 should be used with caution in patients with liver or kidney disease, heart diseases, or a history of lactic acidosis. Your doctor may need to adjust the dosage accordingly.
- Q. Can I skip a dose if my blood sugar is under control?No, it is important to take SYNOGLIM MV 1.3 as prescribed by your doctor even if your blood sugar is under control. Skipping doses may lead to loss of glycemic control.
- Q. What should I do if I experience symptoms of hypoglycemia?If you experience symptoms of hypoglycemia such as dizziness, tremors, sweating, or confusion, you should immediately consume a source of fast-acting glucose, such as glucose tablets or a sugary beverage. Contact your doctor for further instructions.
- Q. Can SYNOGLIM MV 1.3 cause weight gain?Glimepiride, one of the components of SYNOGLIM MV 1.3, may cause weight gain in some individuals. However, the effect may vary from person to person.
- Q. Can SYNOGLIM MV 1.3 be used in type 1 diabetes?No, SYNOGLIM MV 1.3 is not recommended for use in type 1 diabetes. It is specifically indicated for management of type 2 diabetes mellitus.
- Q. Can I stop taking SYNOGLIM MV 1.3 if my blood sugar levels are well-controlled?It is important to continue taking SYNOGLIM MV 1.3 as prescribed by your doctor, even if your blood sugar levels are well-controlled. Stopping the medication without medical guidance may lead to a recurrence of high blood sugar levels.
SYNOGLIM MV 1.3
By SYNODICS LIFESCIENCES PVT LTD
SYNOGLIM MV 1.3 is a fixed dose combination medication that contains Voglibose (0.30mg/Tablet), Metformin (500.00mg/Tablet), and Glimepiride (1.00mg/Tablet). Voglibose is an alpha-glucosidase inhibitor that helps control blood sugar levels by delaying the digestion and absorption of carbohydrates. Metformin is a biguanide that improves insulin sensitivity and reduces glucose production in the liver. Glimepiride is a sulfonylurea that stimulates insulin secretion from the pancreas. This combination is used to manage type 2 diabetes mellitus when diet and exercise alone are not sufficient. It helps lower blood sugar levels and improve glycemic control.
- Management of type 2 diabetes mellitus
- Diarrhea
- Nausea
- Hypoglycemia
- Abdominal pain
- Skin rash
Take SYNOGLIM MV 1.3 orally with meals, as directed by your doctor. The dosage and frequency of administration will depend on your individual medical condition. Follow your doctor's instructions carefully.
- Pregnancy - SYNOGLIM MV 1.3 is not recommended for use during pregnancy. Consult your doctor for safer alternatives.
- Alcohol - It is advisable to avoid alcohol while taking SYNOGLIM MV 1.3 as it may increase the risk of lactic acidosis.
- Old Age - Caution is advised while using SYNOGLIM MV 1.3 in elderly patients, as they may be more prone to the side effects of this medication. Your doctor may need to adjust the dosage accordingly.
- Breast Feeding - SYNOGLIM MV 1.3 is not recommended for use while breastfeeding. Consult your doctor for safer alternatives.
- Children - SYNOGLIM MV 1.3 is not recommended for use in children. Consult your doctor for safer alternatives.
- Store at room temperature (20-25°C) -
- Protect from moisture and light -
- Drug-Drug - This medication may interact with other antidiabetic drugs, beta-blockers, corticosteroids, diuretics, and certain medications metabolized by the liver or kidneys. Inform your doctor about all the medicines you are taking.
- Drug-Food - There are no known significant drug-food interactions with SYNOGLIM MV 1.3.
- Drug-Disease - SYNOGLIM MV 1.3 should be used with caution in patients with liver or kidney disease, heart diseases, or a history of lactic acidosis. Your doctor may need to adjust the dosage accordingly.
- Q. Can I skip a dose if my blood sugar is under control?No, it is important to take SYNOGLIM MV 1.3 as prescribed by your doctor even if your blood sugar is under control. Skipping doses may lead to loss of glycemic control.
- Q. What should I do if I experience symptoms of hypoglycemia?If you experience symptoms of hypoglycemia such as dizziness, tremors, sweating, or confusion, you should immediately consume a source of fast-acting glucose, such as glucose tablets or a sugary beverage. Contact your doctor for further instructions.
- Q. Can SYNOGLIM MV 1.3 cause weight gain?Glimepiride, one of the components of SYNOGLIM MV 1.3, may cause weight gain in some individuals. However, the effect may vary from person to person.
- Q. Can SYNOGLIM MV 1.3 be used in type 1 diabetes?No, SYNOGLIM MV 1.3 is not recommended for use in type 1 diabetes. It is specifically indicated for management of type 2 diabetes mellitus.
- Q. Can I stop taking SYNOGLIM MV 1.3 if my blood sugar levels are well-controlled?It is important to continue taking SYNOGLIM MV 1.3 as prescribed by your doctor, even if your blood sugar levels are well-controlled. Stopping the medication without medical guidance may lead to a recurrence of high blood sugar levels.